Unknown

Dataset Information

0

No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.

ABSTRACT: Postmarketing cases of hepatitis B virus (HBV) reactivation during hepatitis C treatment have been reported. We analyzed serum samples from patients in a clinical trial of ledipasvir-sofosbuvir in Taiwan and Korea. Of the 173 patients enrolled, 103 (60%) had been previously infected with HBV. None showed evidence of HBV reactivation.

SUBMITTER: Sulkowski MS 

PROVIDER: S-EPMC6276897 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.

Sulkowski Mark S MS   Chuang Wan-Long WL   Kao Jia-Horng JH   Yang Jenny C JC   Gao Bing B   Brainard Diana M DM   Han Kwang-Hyub KH   Gane Edward E  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20160802 9

Postmarketing cases of hepatitis B virus (HBV) reactivation during hepatitis C treatment have been reported. We analyzed serum samples from patients in a clinical trial of ledipasvir-sofosbuvir in Taiwan and Korea. Of the 173 patients enrolled, 103 (60%) had been previously infected with HBV. None showed evidence of HBV reactivation. ...[more]

Similar Datasets

Unknown Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir.
| S-EPMC5370780 | biostudies-literature
Unknown Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir.
| S-EPMC4782840 | biostudies-literature
Unknown Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen.
| S-EPMC5700296 | biostudies-literature
Unknown Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response.
| S-EPMC5300778 | biostudies-literature
Unknown Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.
| S-EPMC4738375 | biostudies-other
Unknown Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.
| S-EPMC7491553 | biostudies-literature
Unknown Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naive patients: Findings from two randomized trials.
| S-EPMC5930158 | biostudies-literature
Unknown Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective.
| S-EPMC4902143 | biostudies-literature
Unknown Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir.
| S-EPMC6209576 | biostudies-other
Unknown Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis.
| S-EPMC6034985 | biostudies-literature